
Danilov Lab
@danilovlab
Professor & Director, Early Phase Therapeutics; Co-Director, Lymphoma Center #CLL #lymphoma, translational scientist @cityofhope. Views my own
ID: 1390914034199764996
https://www.cityofhope.org/research/hematologic-malignancies-research-institute/ 08-05-2021 06:18:50
564 Tweet
1,1K Followers
460 Following


📽️ Thanks to Danilov Lab (City of Hope) for stopping by at #ASH24 for an interview on #CLL! ➡️bloodcancerstoday.com/conference/202…


Epcoritamab Monotherapy Induces Complete Responses in R/R CLL Danilov Lab City of Hope ASH #ASH24 #lymsm #hematology onclive.com/view/epcoritam…

In this article, Andrew Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center & Alexey Danilov, MD, PhD from City of Hope discuss when BTK inhibitors & venetoclax should be used as treatment for chronic lymphocytic leukemia: ow.ly/rhcJ50UmBJU MSKHemOncTrials Danilov Lab ASH




Single-agent, subcutaneous epcoritamab generated deep responses in patients with relapsed/refractory chronic lymphocytic leukemia. Danilov Lab City of Hope ASH #ASH24 #lymsm #hematology onclive.com/view/epcoritam…

This is a very important study led by Nilanjan Ghosh, MD, PhD and our lymphoma group at SWOG Cancer Research Network. Let’s finally CURE FL!

👉👉👉Excited to share that Heme Reports team (Nitin Jain Anand Patel Naveen Pemmaraju, MD Kamran Mirza MD PhD - کامران مرزا Sanam Loghavi, MD صنم لغوی 🔬🧬) is hosting a Spaces event for #ASH24 updates in #CLL Tuesday, Jan 14, 6.30-7.30pm CST Guest discussants: Danilov Lab Mazyar Shadman, MD MPH calliecoombs Danielle M. Brander Mazyar Shadman, MD MPH

.SWOG Cancer Research Network S2207 is enrolling patients with relapsed/refractory large B-cell #lymphoma. 3-arm trial adds tazemetostat or zanubrutinib to tafasitamab-lenalidomide. PI: Jennifer Amengual, MD Herbert Irving Comprehensive Cancer Center Columbia Medicine SWOG.org/clinical-trial… #LBCL #lymsm #hematology Lymphoma Research Foundation



Great visit to MD Anderson Cancer Center for Grand rounds. Many thanks to colleagues Paolo Strati Saira Ahmed, MD, FAAP (she/her) Jason Westin, MD FACP FASCO Michael Green, PhD Chris Flowers and all MDACC lymphoma faculty


Today i am celebrating 5 years since our group moved to City of Hope. I am grateful to the institution where, despite the pandemic, we secured two R01s + many foundation grants, published >70 papers, opened a dozen new ISTs and found amazing colleagues and collaborators.


Excited to have Tycel Phillips, Dr. Annie Xiao, Dr. Swetha Kambhampati Thiruvengadam of City of Hope, Dr. Javier Munoz from Mayo Clinic, Dr. Naseem Shams Esteghamat (UC Davis Health), and Brad Haverkos from CU Cancer Center to discuss #nonhodgkins #lymphoma at #HemeLA25! Session


Calling pharmacists! Join us at #HemeLA25 on Mar 28-29 to explore novel agents and complex drug interactions for better patient outcomes in hematologic malignancy treatment. Register NOW: education.binayfoundation.org/content/dogmas… #OncPharm #Pharmacy UCSF Helen Diller Family Comprehensive Cancer Ctr City of Hope UC Davis Health


At City of Hope #MCL Program we moved beyond chemotherapy to treat #MCL. Several trials available for newly diagnosed patients: Glofitamab-, Venetoclax- and Nemtabrutinib-based, individualized to patients based on disease genetics, with exciting early data Tycel Phillips


We're thrilled to bring you some fantastic content from #iwCART25!💉🩸 In an exclusive discussion, Krish Patel, Danilov Lab, and Tycel Phillips share updates on the progress of #CARTCell therapy & bispecific antibodies in #lymphoma: 🎥 ow.ly/6GlJ50VKiT4 #LYMsm #HemOnc
